{
    "root": "a505a386-c2a1-4a32-9523-b33b1528fb48",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Provigil",
    "value": "20221231",
    "ingredients": [
        {
            "name": "MODAFINIL",
            "code": "R3UK8X3U3D"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        }
    ],
    "indications": "provigil indicated improve wakefulness adult patients excessive sleepiness associated narcolepsy , obstructive sleep apnea ( osa ) , shift work disorder ( swd ) . limitations osa , provigil indicated treat excessive sleepiness treatment underlying obstruction . continuous positive airway pressure ( cpap ) treatment choice patient , maximal effort treat cpap adequate period time made prior initiating treatment provigil excessive sleepiness .",
    "contraindications": "recommended provigil indication follows : narcolepsy osa : 200 mg day morning . ( 2.1 ) swd : 200 mg day , taken approximately one hour prior start work shift . ( 2.2 ) severe hepatic impairment : reduce dose half recommended dose . ( 2.3 , 12.3 ) geriatric patients : consider lower dose . ( 2.4 , 12.3 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "provigil contraindicated patients known hypersensitivity modafinil armodafinil inactive ingredients [ ( 5.1 , 5.2 , 5.3 ) ] .",
    "indications_original": "PROVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD).\n                  \n                     Limitations of Use\n                  \n                  In OSA, PROVIGIL is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.  If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with PROVIGIL for excessive sleepiness.",
    "contraindications_original": "The recommended dosage of PROVIGIL for each indication is as follows: Narcolepsy or OSA: 200 mg once a day in the morning. ( 2.1 ) SWD: 200 mg once a day, taken approximately one hour prior to start of the work shift. ( 2.2 ) Severe Hepatic Impairment: reduce dose to half the recommended dose. ( 2.3 , 12.3 ) Geriatric Patients: consider lower dose. ( 2.4 , 12.3 )",
    "adverseReactions_original": "PROVIGIL is contraindicated in patients with known hypersensitivity to modafinil or armodafinil or its inactive ingredients [see Warnings and Precautions (5.1, 5.2, 5.3)]."
}